DSCI
Income statement / Annual
Last year (2015), Derma Sciences, Inc.'s total revenue was $84.47 M,
a decrease of 99.90% from the previous year.
In 2015, Derma Sciences, Inc.'s net income was -$38.11 M.
See Derma Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
FY-2007
|
FY-2006
|
| Period Ended |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
12/31/2010 |
12/31/2009 |
12/31/2008 |
12/31/2007 |
12/31/2006 |
| Operating Revenue |
$84.47 M |
$83.75 B |
$79.71 B |
$72.65 B |
$62.63 M |
$56.47 B |
$48.53 B |
$50.20 B |
$34.14 B |
$27.89 B |
| Cost of Revenue |
$51.74 M
|
$53.64 B
|
$50.32 B
|
$47.51 B
|
$44.22 M
|
$39.95 B
|
$33.47 B
|
$35.29 B
|
$22.53 B
|
$18.24 B
|
| Gross Profit |
$32.73 M
|
$30.11 B
|
$29.39 B
|
$25.14 B
|
$18.41 M
|
$16.53 B
|
$15.06 B
|
$14.91 B
|
$11.60 B
|
$9.65 B
|
| Gross Profit Ratio |
0.39
|
0.36
|
0.37
|
0.35
|
0.29
|
0.29
|
0.31
|
0.3
|
0.34
|
0.35
|
| Research and Development Expenses |
$807.13 K
|
$19.25 B
|
$11.34 B
|
$7.12 B
|
$1.06 M
|
$292.66 M
|
$399.56 M
|
$653.33 M
|
$993.07 M
|
$0.00
|
| General & Administrative Expenses |
$51.43 B
|
$50.96 B
|
$42.04 B
|
$32.49 B
|
$21.17 M
|
$17.91 B
|
$15.14 B
|
$17.20 B
|
$11.89 B
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$51.43 B
|
$50.96 B
|
$42.04 B
|
$32.49 B
|
$21.17 M
|
$17.91 B
|
$15.14 B
|
$17.20 B
|
$11.89 B
|
$0.00
|
| Other Expenses |
-$51.38 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$8.34 B
|
| Operating Expenses |
$54.70 M
|
$70.21 B
|
$53.38 B
|
$39.61 B
|
$22.23 M
|
$18.20 B
|
$15.53 B
|
$17.85 B
|
$12.88 B
|
$8.34 B
|
| Cost And Expenses |
$106.44 M
|
$123.85 B
|
$103.70 B
|
$87.12 B
|
$66.45 M
|
$58.14 B
|
$49.00 B
|
$53.14 B
|
$35.41 B
|
$26.57 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$263.06 K
|
-$580.62 M
|
-$842.13 M
|
-$940.15 M
|
-$413.99 M
|
-$374.08 M
|
| Depreciation & Amortization |
$3.91 M
|
$868.05 M
|
$878.15 M
|
$1.02 B
|
$2.64 M
|
$895.26 M
|
$882.60 M
|
$855.61 M
|
$773.28 M
|
$611.23 M
|
| EBITDA |
-$36.44 M |
-$39.05 B |
-$22.93 B |
-$13.42 B |
-$1.37 M |
-$2.13 B |
-$1.03 B |
-$3.99 B |
-$1.66 B |
$1.02 B |
| EBITDA Ratio |
-0.43
|
-0.47
|
-0.29
|
-0.18
|
-0.02
|
-0.04
|
-0.02
|
-0.08
|
-0.05
|
0.04
|
| Operating Income Ratio |
-0.26
|
-0.48
|
-0.3
|
-0.2
|
-0.06
|
-0.04
|
-0.02
|
-0.08
|
-0.04
|
0.03
|
| Total Other Income/Expenses Net |
-$649.78 K
|
$0.00
|
$0.00
|
$0.00
|
-$451.84 K
|
$0.00
|
$0.00
|
$0.00
|
-$748.55 M
|
$0.00
|
| Income Before Tax |
-$22.61 M
|
-$39.92 B
|
-$23.80 B
|
-$14.44 B
|
-$4.27 M
|
-$2.02 B
|
-$1.07 B
|
-$3.90 B
|
-$2.02 B
|
$787.08 M
|
| Income Before Tax Ratio |
-0.27
|
-0.48
|
-0.3
|
-0.2
|
-0.07
|
-0.04
|
-0.02
|
-0.08
|
-0.06
|
0.03
|
| Income Tax Expense |
-$2.24 M
|
-$151.05 M
|
$160.11 M
|
-$2.37 B
|
$69.54 K
|
-$580.62 M
|
$68.66 M
|
$58.82 M
|
$262.03 M
|
$118.34 M
|
| Net Income |
-$38.11 M
|
-$39.77 B
|
-$23.96 B
|
-$12.07 B
|
-$4.34 M
|
-$2.45 B
|
-$1.14 B
|
-$3.96 B
|
-$2.28 B
|
$668.74 M
|
| Net Income Ratio |
-0.45
|
-0.47
|
-0.3
|
-0.17
|
-0.07
|
-0.04
|
-0.02
|
-0.08
|
-0.07
|
0.02
|
| EPS |
-1.47 |
-1535.75 |
-1411.52 |
-1000.16 |
-0.37 |
-38.65 |
-22.72 |
-102.62 |
-86.13 |
25.21 |
| EPS Diluted |
-1.47 |
-1535.75 |
-1411.52 |
-1000.16 |
-0.37 |
-38.65 |
-22.72 |
-102.62 |
-86.13 |
25.21 |
| Weighted Average Shares Out |
$25.90 M
|
$25.90 M
|
$16.98 M
|
$12.07 M
|
$11.66 M
|
$63.36 M
|
$50.32 M
|
$38.61 M
|
$26.52 M
|
$26.52 M
|
| Weighted Average Shares Out Diluted |
$25.90 M
|
$25.90 M
|
$16.98 M
|
$12.07 M
|
$11.66 M
|
$63.36 M
|
$50.32 M
|
$38.61 M
|
$26.52 M
|
$26.52 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
